Reasons why methylcobalamin injection (Rozebalamin) is ineffective in treating tinnitus for six days and suggestions for subsequent adjustments
Methylcobalamin injection (Rozebalamin) is the latest neuroprotective drug developed in Japan for the treatment of amyotrophic lateral sclerosis (ALS, ALS). Its mechanism of action is to promote motor neuron metabolism and myelin repair by providing active vitamin B12 form, thereby delaying neurodegenerative damage. In ALS patients, the drug is mainly used to improve motor nerve function and slow down the progression of muscle atrophy and movement disorders.
If it is used to treat tinnitus or neurological function improvement in ALS related symptoms, it is a common clinical phenomenon that no effect is seen for six days. ALSNeurodegeneration in ALS patients usually develops slowly and complexly, and it takes a long time for nerve repair and functional improvement to be noticeable. If no obvious relief is seen within six days of short-term medication, it does not mean that the medication is ineffective, but that it requires continued use for a longer period of time to exert a neuroprotective effect.

Recommendations for subsequent adjustments include continued long-term use as directed by the doctor, and combined with overall condition assessment for individualized dose management. For ALS patients, methylcobalamin injection generally needs to be continued for weeks to months to observe the efficacy. Doctors may fine-tune the dose based on the patient's weight, disease severity, and tolerance. In addition, rehabilitation training, physical therapy and symptomatic supportive care can be combined to improve muscle function and quality of life.
Clinically, attention should also be paid to the patient's overall neurological status and possible accompanying symptoms. If symptoms do not improve within six days, regular follow-up should be maintained to evaluate motor function, respiratory function and other ALS related indicators. Under the guidance of a doctor, scientifically adjust the treatment course and dosage to ensure the safety and effectiveness of long-term use of the drug, thereby maximizing the potential benefits of methylcobalamin injection in the treatment of ALS.
Keyword tag:
ALS (ALS), neuroprotection, vitaminsB12, nerve repair, clinical trials, drug prices, imported drugs, no generic drugs, regular drug purchase channels
Reference materials:https://pubmed.ncbi.nlm.nih.gov/?term=mecobalamin
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)